Quick Takeaways
- CITADEL ADVISORS LLC filed SCHEDULE 13G for PLIANT THERAPEUTICS, INC. Common Stock, par value $0.0001 per share (the "Shares") (PLRX).
- Disclosed ownership: 4.9%.
- Date of event: 23 Jan 2026.
Quoteable Key Fact
"CITADEL ADVISORS LLC disclosed 4.9% ownership in PLIANT THERAPEUTICS, INC. Common Stock, par value $0.0001 per share (the "Shares") (PLRX) on 23 Jan 2026."
Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.
| Name | Ownership | Shares Owned | sole voting power | shared voting power | Signature | Title | CIK |
|---|---|---|---|---|---|---|---|
| Citadel Advisors LLC | 3.4% | 2,099,798 | 0 | 2,099,798 | /s/ Seth Levy | Seth Levy, Authorized Signatory | |
| Citadel Advisors Holdings LP | 3.4% | 2,099,798 | 0 | 2,099,798 | /s/ Seth Levy | Seth Levy, Authorized Signatory | |
| Citadel GP LLC | 3.4% | 2,099,798 | 0 | 2,099,798 | /s/ Seth Levy | Seth Levy, Authorized Signatory | |
| Citadel Securities LLC | 1.5% | 909,171 | 0 | 909,171 | /s/ Seth Levy | Seth Levy, Authorized Signatory | |
| Citadel Securities Group LP | 1.5% | 937,897 | 0 | 937,897 | /s/ Seth Levy | Seth Levy, Authorized Signatory | |
| Citadel Securities GP LLC | 1.5% | 937,897 | 0 | 937,897 | /s/ Seth Levy | Seth Levy, Authorized Signatory | |
| Kenneth Griffin | 4.9% | 3,037,695 | 0 | 3,037,695 | /s/ Seth Levy | Seth Levy, attorney-in-fact* |